<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
<channel>
<title>PIRIBO LTD - PRWeb Press Release Account Feed</title>
<link>http://www.rsspad.com/rss2a/107299.xml</link>
<description>PIRIBO LTD - Press Releases</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
     <title>Global Orthopaedic Drug Market to Reach $44 Billion by 2010, Says New Report Available from Piribo.com</title>
     <link>http://www.prweb.com/releases/2006/11/prweb476223.htm</link><description>   <![CDATA[ <P>Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a report on the global market for orthopaedic drugs. &quot;The Worldwide Market for Prescription Orthopedic Drugs&quot; (http://www.piribo.com/search/results.html?k=kal093&#38;x=0&#38;y=0) forecasts that the market will grow significantly in the next four years from 2005 market size of $26.8 billion. (PRWeb Nov 10, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/11/prweb476223.htm">http://www.prweb.com/releases/2006/11/prweb476223.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/11/prweb476223.htm</guid>
        </item>
<item>
     <title>Piribo: New Report on Prospects for Injectable Generic Drugs</title>
     <link>http://www.prweb.com/releases/2006/10/prweb457907.htm</link><description>   <![CDATA[ <P>Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a key market report on injectable generics drugs. (PRWeb Oct 26, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/10/prweb457907.htm">http://www.prweb.com/releases/2006/10/prweb457907.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/10/prweb457907.htm</guid>
        </item>
<item>
     <title>Injectable Drug Delivery Market to Grow at 15%, Predicts New Report Available from Piribo</title>
     <link>http://www.prweb.com/releases/2006/10/prweb448858.htm</link><description>   <![CDATA[ <P>Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a key market report on injectable drug delivery systems. (PRWeb Oct 11, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/10/prweb448858.htm">http://www.prweb.com/releases/2006/10/prweb448858.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/10/prweb448858.htm</guid>
        </item>
<item>
     <title>Piribo: U.S. Market for IV Therapy and Vein Access, New Publication Announcement</title>
     <link>http://www.prweb.com/releases/2006/09/prweb439089.htm</link><description>   <![CDATA[ <P>Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called &#8220;U.S. Market for IV Therapy and Vein Access.&#8221; http://www.piribo.com/publications/technology/us_market_for_iv_therapy_vein_access.html (PRWeb Sep 20, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/09/prweb439089.htm">http://www.prweb.com/releases/2006/09/prweb439089.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2006/09/prweb439089.htm</guid>
        </item>
<item>
     <title>Piribo: Paper Outlines the Key Factors in Successful Patient Recruitment for Clinical Trials</title>
     <link>http://www.prweb.com/releases/2005/12/prweb322016.htm</link><description>   <![CDATA[ <P>Today, Piribo (piribo.com), the dedicated online store for pharmaceutical business information products, publishes a short paper on successful patient recruitment for pharmaceutical clinical trials. (PRWeb Dec 15, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/12/prweb322016.htm">http://www.prweb.com/releases/2005/12/prweb322016.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2005/12/prweb322016.htm</guid>
        </item>
<item>
     <title>Bonuses Account for Over a Third of Pharmaceutical Company Director&#8217;s Earnings, Finds Piribo Salary Report</title>
     <link>http://www.prweb.com/releases/2005/03/prweb216131.htm</link><description>   <![CDATA[ <P>The average pharmaceutical company executive director in the UK receives 39 percent of their total remuneration package in the form of a bonus, according to Piribo Ltd, which today released its report UK Pharmaceutical Executive Pay - Insight into Director Remuneration. The report found that the average bonus paid to an executive director on the board of a UK pharmaceutical company is 163,000 while the median value is 55,000. Most bonuses are performance-orientated dependant on preset targets of net income, turnover or even earnings per share before amortisation (EPSA). (PRWeb Mar 9, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/03/prweb216131.htm">http://www.prweb.com/releases/2005/03/prweb216131.htm</a></P>]]>
                </description>
        <guid isPermaLink="true">http://www.prweb.com/releases/2005/03/prweb216131.htm</guid>
        </item>
</channel>
</rss>